GENE ONLINE|News &
Opinion
Blog

2025-04-28|

Merck KGaA to Acquire SpringWorks Therapeutics After Negotiations

by Mark Chiang
Share To

NEWSFLASH

Merck KGaA announced its intention to acquire SpringWorks Therapeutics following several months of negotiations. The announcement confirms the completion of a deal that will see SpringWorks Therapeutics become part of Merck KGaA. The acquisition comes after extensive discussions between the two companies. The agreement signifies a strategic move by Merck KGaA to expand its portfolio through the acquisition of SpringWorks Therapeutics and their related assets. The specific details of the deal, including financial terms, were not disclosed in the announcement.

Newsflash | Powered by GeneOnline AI
Date: April 28, 2025

©www.geneonline.com All rights reserved. Collaborate with us: [email protected]
Related Post
A Look at Taiwan-German Collaborative Solutions in Precision Medicine, Drug Development, and Medical Tech
2025-05-21
LATEST
A Look at Taiwan-German Collaborative Solutions in Precision Medicine, Drug Development, and Medical Tech
2025-05-21
ACOG Updates Pain Management Guidelines for IUD Insertions as Novavax Vaccine Gains Approval
2025-05-20
NIH Restores Research Funding to Previously Defunded Scientists Amid Policy Shifts
2025-05-20
Prime Medicine Reduces Workforce by 25 Percent and Appoints David Schenkein as New CEO
2025-05-20
UnitedHealth Group Stock Drops Amid Rising Medicare Advantage Costs and Regulatory Debates
2025-05-20
Trump Science Adviser Michael Kratsios Calls for Renewed Focus on Reproducible Research Practices to Address Scientific Stagnation
2025-05-20
House Republicans Propose $700 Billion Medicaid Savings with Work Requirements
2025-05-20
EVENT
2025-05-30
ASCO Annual Meeting 2025
Chicago, U.S.A
2025-06-11
ISSCR 2025 Annual Meeting
Hong Kong
2025-06-16
US BIO International Convention
Boston, U.S.A.
Scroll to Top